{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:38:19Z","timestamp":1772836699905,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","award":["2016-I2M-2-004"],"award-info":[{"award-number":["2016-I2M-2-004"]}]},{"name":"Graduate Innovative Program of Peking Union Medical College","award":["2017-1002-2-05"],"award-info":[{"award-number":["2017-1002-2-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00261-019-02022-2","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T09:05:31Z","timestamp":1556183131000},"page":"2801-2808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Transcatheter arterial infusion for pancreatic cancer: a 10-year National Cancer Center experience in 115 patients and literature review"],"prefix":"10.1007","volume":"44","author":[{"given":"Bin","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaywei","family":"Tsauo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"2022_CR1","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, et al. (2016) Pancreatic cancer. Nat Rev Dis Primers 2:16022","journal-title":"Pancreatic cancer. Nat Rev Dis Primers"},{"key":"2022_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913\u20132921","journal-title":"Cancer Res"},{"key":"2022_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrclinonc.2009.236","volume":"7","author":"A Stathis","year":"2010","unstructured":"Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7:163\u2013172","journal-title":"Nat Rev Clin Oncol"},{"key":"2022_CR4","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1200\/JCO.2008.17.7188","volume":"27","author":"CA Iacobuzio-Donahue","year":"2009","unstructured":"Iacobuzio-Donahue CA, Fu B, Yachida S et al. (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27:1806\u20131813","journal-title":"J Clin Oncol"},{"key":"2022_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017. CA Cancer J Clin 67:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"2022_CR6","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.6004\/jnccn.2017.0131","volume":"15","author":"MA Tempero","year":"2017","unstructured":"Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15:1028\u20131061","journal-title":"J Natl Compr Canc Netw"},{"key":"2022_CR7","doi-asserted-by":"crossref","unstructured":"Chin V, Nagrial A, Sjoquist K et al (2018) Chemotherapy and radiotherapy for advanced pancreatic cancer. Cochrane Database Syst Rev 3:CD011044","DOI":"10.1002\/14651858.CD011044.pub2"},{"key":"2022_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrclinonc.2015.78","volume":"12","author":"A Habib","year":"2015","unstructured":"Habib A, Desai K, Hickey R et al (2015) Transarterial approaches to primary and secondary hepatic malignancies. Nat Rev Clin Oncol 12:481\u2013489","journal-title":"Nat Rev Clin Oncol"},{"key":"2022_CR9","first-page":"917","volume":"43","author":"DJ Stewart","year":"1983","unstructured":"Stewart DJ, Benjamin RS, Zimmerman S et al (1983) Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). Cancer Res 43:917\u2013920","journal-title":"Cancer Res"},{"key":"2022_CR10","unstructured":"Liu F, Tang Y, Sun J et al (2012) Regional intra-arterial vs. systemic chemotherapy for advanced pancreatic cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS One 7:e40847"},{"key":"2022_CR11","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","volume":"24","author":"NE Kemeny","year":"2006","unstructured":"Kemeny NE, Niedzwiecki D, Hollis DR et al (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395\u20131403","journal-title":"J Clin Oncol"},{"key":"2022_CR12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(94)90750-1","volume":"344","author":"TG Allen-Mersh","year":"1994","unstructured":"Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J (1994) Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344:1255\u20131260","journal-title":"Lancet"},{"key":"2022_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/annonc\/mdm528","volume":"19","author":"A Ganeshan","year":"2008","unstructured":"Ganeshan A, Upponi S, Hon LQ, Warakaulle D, Uberoi R (2008) Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology. Ann Oncol 19:847\u2013851","journal-title":"Ann Oncol"},{"key":"2022_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"2022_CR15","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","volume":"14","author":"D Sacks","year":"2003","unstructured":"Sacks D, McClenny TE, Cardella JF, Lewis CA (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199\u2013202","journal-title":"J Vasc Interv Radiol"},{"key":"2022_CR16","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.7314\/APJCP.2012.13.6.2669","volume":"13","author":"GB Hong","year":"2012","unstructured":"Hong GB, Zhou JX, Sun HB, Li CY, Song LQ (2012) Continuous transarterial infusion chemotherapy with gemcitabine and 5-Fluorouracil for advanced pancreatic carcinoma. Asian Pac J Cancer Prev 13:2669\u20132673","journal-title":"Asian Pac J Cancer Prev"},{"key":"2022_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/CAD.0000000000000120","volume":"25","author":"Y Chen","year":"2014","unstructured":"Chen Y, Wang XL, Wang JH et al (2014) Transarterial infusion with gemcitabine and oxaliplatin for the treatment of unresectable pancreatic cancer. Anticancer Drugs 25:958\u2013963","journal-title":"Anticancer Drugs"},{"key":"2022_CR18","doi-asserted-by":"publisher","first-page":"e3098","DOI":"10.1097\/MD.0000000000003098","volume":"95","author":"X Liu","year":"2016","unstructured":"Liu X, Yang X, Zhou G et al (2016) Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma. Medicine (Baltimore) 95:e3098","journal-title":"Medicine (Baltimore)"},{"key":"2022_CR19","unstructured":"Liu H, Li Y, Huang R, Huang X (2008) Clinical Observation of Transarterial Infusion Chemotherapy of GP for Treatment of Advanced Pancreatic Carcinoma. Journal of Basic & Clinical Oncology"},{"key":"2022_CR20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2165\/00003088-200544090-00005","volume":"44","author":"AI Shamseddine","year":"2005","unstructured":"Shamseddine AI, Khalifeh MJ, Mourad FH et al (2005) Comparative pharmacokinetics and metabolic pathway of gemcitabine during intravenous and intra-arterial delivery in unresectable pancreatic cancer patients. Clin Pharmacokinet 44:957\u2013967","journal-title":"Clin Pharmacokinet"},{"key":"2022_CR21","first-page":"89","volume":"116","author":"Z Ji","year":"2003","unstructured":"Ji Z, Wang Y, Chen X, Wu T (2003) Peripancreatic artery ligation and artery infusion chemotherapy for advanced pancreatic carcinoma. Chin Med J (Engl) 116:89\u201392","journal-title":"Chin Med J (Engl)"},{"key":"2022_CR22","first-page":"1125","volume":"45","author":"KR Aigner","year":"1998","unstructured":"Aigner KR, Gailhofer S, Kopp S (1998) Regional versus systemic chemotherapy for advanced pancreatic cancer: a randomized study. Hepatogastroenterology 45:1125\u20131129","journal-title":"Hepatogastroenterology"},{"key":"2022_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1443-9573.2006.00243.x","volume":"7","author":"GH Han","year":"2006","unstructured":"Han GH, Yin ZX, Meng XJ et al (2006) Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma. Chin J Dig Dis 7:45\u201348","journal-title":"Chin J Dig Dis"},{"key":"2022_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10330-007-0086-4","volume":"6","author":"G Hong","year":"2007","unstructured":"Hong G, Zhou J, Luo J, Xu L, Chen Y, Jiang R (2007) A clinical study on continuous transarterial infusion chemotherapy and systemic venous chemotherapy with gemcitabine and 5-fluorouracil in treating patients with advanced pancreatic carcinoma. Chinese-German Journal of Clinical Oncology 6:457\u2013460","journal-title":"Chinese-German Journal of Clinical Oncology"},{"key":"2022_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jvir.2016.10.023","volume":"28","author":"G Narayanan","year":"2017","unstructured":"Narayanan G, Hosein PJ, Beulaygue IC et al (2017) Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma. J Vasc Interv Radiol 28:342\u2013348","journal-title":"J Vasc Interv Radiol"},{"key":"2022_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1148\/radiol.2016152835","volume":"282","author":"HJ Scheffer","year":"2017","unstructured":"Scheffer HJ, Vroomen LG, de Jong MC et al (2017) Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I\/II PANFIRE Study. Radiology 282:585\u2013597","journal-title":"Radiology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-019-02022-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-019-02022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T23:17:53Z","timestamp":1587683873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-019-02022-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1007\/s00261-019-02022-2","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"25 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}